A comparison between alpha-fetoprotein and p53 antibodies in the diagnosis of hepatocellular carcinoma.
Edis
C
C
University of Innsbruck, Department of Gastroenterology, Austria.
Kähler
C
C
Klotz
W
W
Herold
M
M
Feichtinger
H
H
Königsreiner
A
A
Margreiter
R
R
Jaschke
W
W
Vogel
W
W
D001323:Autoantibodies / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood* / Q000276:immunology; D006528:Carcinoma, Hepatocellular / Q000097:blood / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D002471:Cell Transformation, Neoplastic; D003937:Diagnosis, Differential; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood / Q000175:diagnosis* / Q000601:surgery; D008107:Liver Diseases / Q000097:blood / Q000175:diagnosis* / Q000601:surgery; D008113:Liver Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D016031:Liver Transplantation; D011863:Radioimmunoassay; D016159:Tumor Suppressor Protein p53 / Q000276:immunology*; D000509:alpha-Fetoproteins / Q000032:analysis* / Q000276:immunology
D001323:Autoantibodies; D014408:Biomarkers, Tumor; D016159:Tumor Suppressor Protein p53; D000509:alpha-Fetoproteins